Importantly, a subset of patients (6%) showed true biological discordance, often linked to APOE ε4 or mixed/non-AD pathologies, underscoring the role of biomarker heterogeneity in symptomatic cohorts. This evidence concerns the gene APOE and Alzheimer disease.